Mural Oncology Plc Stock Buy Hold or Sell Recommendation

MURA Stock   3.44  0.20  5.49%   
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Mural Oncology plc is 'Strong Buy'. Macroaxis provides Mural Oncology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MURA positions.
  
Check out Mural Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Mural and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Mural Oncology Buy or Sell Advice

The Mural recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mural Oncology plc. Macroaxis does not own or have any residual interests in Mural Oncology plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mural Oncology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Mural OncologyBuy Mural Oncology
Strong Buy

Market Performance

WeakDetails

Volatility

Slightly riskyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Quite HighDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Mural Oncology plc has a Risk Adjusted Performance of 0.034, Jensen Alpha of 0.0375, Total Risk Alpha of (0.23), Sortino Ratio of 0.0118 and Treynor Ratio of 0.1167
We provide investment recommendation to complement the last-minute expert consensus on Mural Oncology plc. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Mural Oncology plc is not overpriced, please verify all Mural Oncology plc fundamentals, including its book value per share, as well as the relationship between the target price and retained earnings . Given that Mural Oncology plc has a shares owned by institutions of 69.43 %, we recommend you to check Mural Oncology market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Mural Oncology Trading Alerts and Improvement Suggestions

Mural Oncology plc had very high historical volatility over the last 90 days
Mural Oncology plc has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (207.45 M) with profit before overhead, payroll, taxes, and interest of 0.
Mural Oncology generates negative cash flow from operations
Mural Oncology plc has a frail financial position based on the latest SEC disclosures
About 69.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635

Mural Oncology Returns Distribution Density

The distribution of Mural Oncology's historical returns is an attempt to chart the uncertainty of Mural Oncology's future price movements. The chart of the probability distribution of Mural Oncology daily returns describes the distribution of returns around its average expected value. We use Mural Oncology plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mural Oncology returns is essential to provide solid investment advice for Mural Oncology.
Mean Return
0.12
Value At Risk
-5.22
Potential Upside
4.76
Standard Deviation
3.19
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mural Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Mural Oncology Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mural Oncology or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mural Oncology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mural stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.04
β
Beta against Dow Jones0.91
σ
Overall volatility
3.21
Ir
Information ratio 0.01

Mural Oncology Volatility Alert

Mural Oncology plc currently demonstrates below-average downside deviation. It has Information Ratio of 0.01 and Jensen Alpha of 0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Mural Oncology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Mural Oncology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Mural Oncology Fundamentals Vs Peers

Comparing Mural Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mural Oncology's direct or indirect competition across all of the common fundamentals between Mural Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mural Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mural Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mural Oncology by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Mural Oncology to competition
FundamentalsMural OncologyPeer Average
Return On Equity-1.78-0.31
Return On Asset-0.81-0.14
Current Valuation(103.86 M)16.62 B
Shares Outstanding17.06 M571.82 M
Shares Owned By Insiders1.14 %10.09 %
Shares Owned By Institutions69.43 %39.21 %
Number Of Shares Shorted476.66 K4.71 M
Price To Book0.36 X9.51 X
EBITDA(192.72 M)3.9 B
Net Income(207.45 M)570.98 M
Total Debt15.01 M5.32 B
Book Value Per Share15.81 X1.93 K
Cash Flow From Operations(194.25 M)971.22 M
Short Ratio3.85 X4.00 X
Earnings Per Share(9.03) X3.12 X
Target Price16.33
Number Of Employees10718.84 K
Market Capitalization62.1 M19.03 B
Total Asset301.75 M29.47 B
Retained Earnings(30.86 M)9.33 B
Working Capital248.32 M1.48 B
Net Asset301.75 M
Note: Disposition of 5069 shares by Goodman Vicki L of Mural Oncology at 3.33 subject to Rule 16b-3 [view details]

Mural Oncology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mural . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Mural Oncology Buy or Sell Advice

When is the right time to buy or sell Mural Oncology plc? Buying financial instruments such as Mural Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Mural Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipping Containers Thematic Idea Now

Shipping Containers
Shipping Containers Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:
Check out Mural Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.03)
Return On Assets
(0.81)
Return On Equity
(1.78)
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.